U.S. Stock Market IPO: KKR-backed ambulance giant GMR makes debut raises $478.7 million, down from originally proposed $797.9 million

Emergency medical ​services provider GMR ‌Solutions ⁠has ⁠raised $478.7 ​million in ​its ​U.S. ⁠initial public offering, ‌the ​company ​said ⁠on Tuesday. The Lewisville, Texas-based company, known as Global Medical Response, was seeking $478.7 million in the IPO ‌by marketing 31.9 ⁠million shares ⁠at $15 apiece, down from its plan to raise as much as $797.9 million at a ​proposed range of $22 to $25 apiece.





Earlier on Tuesday, emergency medical services provider GMR Solutions slashed the valuation target of its U.S. initial public offering to about $3.3 billion from $5 billion, as investors remain selective about new listings.




While the spring IPO market has been encouraging after the brief lull in March, analysts caution the IPO window remains uneven, with investors being selective as to where they deploy capital.




"Today's price cut signals ​that the recent IPO pick-up is still somewhat ⁠precarious. Investors ‌are anxious to participate in hot IPOs, but content ​to pass ​over the less-exciting stories," said Matt Kennedy, senior strategist ⁠at Renaissance Capital, a provider of IPO-focused research and ETFs.




Kennedy ​pointed to GMR's "debt level and relatively slow growth to ​explain the weak investor reception so far."




GMR, which completed a $5.4 billion refinancing in 2025, is a heavyweight in providing essential emergency medical services, with operations spanning roughly 1,400 U.S. counties. It had roughly $5 billion in long-term debt as of December 31.




The company expects revenue between $1.42 billion ‌and $1.46 billion for the three months ended March 31, compared with $1.37 billion a year earlier.




"When debt constitutes such a large ​piece of ​the valuation, sponsors need ⁠to slash the equity value to have a meaningful impact. This can eventually benefit investors if the company executes well and deleverages over time," Kennedy ​said.




Funds affiliated with investment firms KKR, Ares and HPS are expected to buy $500 million of private placement warrants. They had earlier planned to buy $350 million of warrants.




J.P. Morgan, KKR and BofA Securities are among the underwriters.